COMPARE THE EVIDENCE

SLU-PP-332

Findings, possible implications, and reported experiences.

About SLU-PP-332

Small moleculeMetabolism

Primary research area: Emerging research
Regulatory status: Research status varies
Evidence level: Evidence level not yet characterized
Primary mechanism: Mechanism not yet characterized

Reference profile available · Coverage varies by section

Also known as SLUPP332

SLU-PP-332 is an experimental small molecule that activates estrogen-related receptors, a group of nuclear receptors involved in energy metabolism. It is being studied as a mitochondrial and endurance-related research compound. [1]

What has been observed?

Selected source-linked reading notes, not the complete literature or a pooled conclusion.

Animal · Reading scope not recorded

Does the exercise-mimetic mechanism translate into performance?

Mouse and cell experiments; not a human intervention trial.

ERR activation increased respiration in muscle cells and improved running endurance in mice.

Limits: Human exposure, effectiveness and safety are unresolved by this experiment. Exercise-like signaling does not establish human muscle growth.

Open primary source · Read interpretation separately

Explore outcomes for this compound

Uses & research: The cited study tested receptor activity, cellular respiration and exercise-related outcomes in mice. It did not test people. [1]
Known half-life: No source-verified value in this profile yet. A treatment schedule or duration of an effect is not a drug half-life.
Half-life describes how quickly the measured drug concentration falls by half. It does not set a dosing interval.
Evidence & important limits: The available source provides preclinical cell and mouse findings, not a human half-life, human safety profile or demonstrated human performance benefit. Mechanistic plausibility cannot be converted into a human effect estimate. [1]

Safety & evidence boundaries

Source-specific information, not a personal safety clearance or monitoring plan.

The available source provides preclinical cell and mouse findings, not a human half-life, human safety profile or demonstrated human performance benefit. Mechanistic plausibility cannot be converted into a human effect estimate.

Fu et al., SLU-PP-332 ERR agonist study (2023)

Explore safety questions by system

These are literature filters, not claims that this compound causes each effect. A keyword match is not a confirmed adverse reaction.

Heart, blood pressure & lipids Liver injury Kidney function Glucose effects Reproductive & endocrine effects Mood & sleep Adverse effects & interactions

Interactions, rare harms, long-term effects and reversibility require separate evidence. Do not infer they are absent when the sources here do not address them.

Identity, names & formulations

Canonical compound: SLU-PP-332 · slupp332

Searchable names: SLUPP332

Names share a parent research page. Different esters, salts, routes and brands are not assumed to have the same half-life, indication or exposure.

Often typed SLU-PP-322. The published compound is SLU-PP-332; 322 is treated as a search correction, not a verified chemical synonym.

Combination evidence stays attached to the studied combination. It is not automatically assigned to each ingredient.

Understand the evidence types

Read the model and design first, then the population, outcome and limitations. These categories describe evidence, not a best-compound ranking.

Randomized human trials: Compare assigned interventions. Randomization does not by itself establish low bias or relevance to every population.
Controlled human studies: Use a comparison group; allocation and confounding still matter.
Prospective human research: Follows participants forward. It may be observational or interventional, so this is not a separate quality grade.
Observational human research: Describes associations. Confounding can explain differences.
Case reports and series: Useful for unusual events and safety signals, not reliable rates or effect sizes.
Animal research: Can test biology and function in a living model. Human exposure, benefit and safety remain separate questions.
Cell and tissue research: Tests responses in a preparation, including human-derived cells. It is not a human participant trial.
Mechanistic and computational evidence: Helps explain or predict a pathway; predictions need experimental and clinical testing.
Anecdotal reports: Self-reported experiences can generate questions. Product identity, selection bias and other interventions may be uncontrolled.

Systematic reviews synthesize studies and depend on their quality. Preprint status and abstract versus full-paper reading are separate labels. Citation popularity measures attention, not reliability. A study summary is not a formal quality appraisal.

Sources for this profile

1. Fu et al., SLU-PP-332 ERR agonist study (2023) Study abstract · cell and mouse research

Reference facts checked 2026-09-16. Source scope is listed above; this is not a formal quality appraisal. See each label for full prescribing information.

Browse all studies

Research outcomeResearch model

Study model describes the source. Confidence depends on methods, replication, population and outcome.

Loading compound research…